These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9834751)

  • 1. For aggressive preventive management of type 2 diabetes. What is the evidence and is it enough?
    Genuth S
    J Fam Pract; 1998 Nov; 47(5 Suppl):S23-6. PubMed ID: 9834751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventing cardiovascular disease in type 2 diabetes. From evidence based medicine to patient based reality].
    Arnold-Kunz G; Ruiz J
    Rev Med Suisse; 2007 Jun; 3(114):1456-8, 1460-2. PubMed ID: 17639667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evidence-based reduction of complications of type 2 diabetes following intensive antihypertensive treatment].
    Hansen KW; Poulsen PL; Mogensen CE
    Ugeskr Laeger; 1999 Aug; 161(34):4764. PubMed ID: 10500468
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for type 2 diabetes mellitus in adults.
    Fink K; Clark B
    Am Fam Physician; 2004 Feb; 69(3):605-6. PubMed ID: 14971844
    [No Abstract]   [Full Text] [Related]  

  • 6. Multitherapy for diabetes.
    Harris SB
    CMAJ; 2006 Nov; 175(10):1247-8. PubMed ID: 17098959
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies to improve diabetes care.
    Bodenheimer T
    Am Fam Physician; 2003 Oct; 68(8):1500, 1503-4, 1506. PubMed ID: 14596438
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PPAR agonists do not come up to expectations. Hope about the preventive effect in type 2 diabetes has come to nought].
    Olsson AG
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2454-5. PubMed ID: 17002160
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy and clinical trials: diabetes and cardiovascular risk.
    Peter R
    Curr Opin Lipidol; 2008 Feb; 19(1):101-3. PubMed ID: 18196995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Time for a European perspective on cardiovascular prevention].
    Nilsson PM; Perk J; Rydén L
    Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
    Deedwania PC; Fonseca VA
    Am J Med; 2005 Sep; 118(9):939-47. PubMed ID: 16164876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of ischemic cardiovascular complications in type 2 diabetes].
    Moulin P
    Journ Annu Diabetol Hotel Dieu; 2000; ():125-37. PubMed ID: 10932875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH; Huijberts MS
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of body iron stores and the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
    Edelman SV
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S29-37. PubMed ID: 14668701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing cardiovascular disease risk in patients with type 2 diabetes: a message from the National Diabetes Education Program.
    Gavin JR; Peterson K; Warren-Boulton E;
    Am Fam Physician; 2003 Oct; 68(8):1569-74. PubMed ID: 14596445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.